Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

462 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-SMN autoantibodies in mixed connective tissue disease are associated with a severe systemic sclerosis phenotype.
El Kamouni H, S Jalaledin D, Albert A, Hoa S, Vo C, Bourré-Tessier J, Rich É, Goulet JR, Koenig M, Pérez G, Choi MY, Troyanov Y, Satoh M, Fritzler MJ, Senécal JL, Landon-Cardinal O. El Kamouni H, et al. Among authors: fritzler mj. RMD Open. 2023 Oct;9(4):e003431. doi: 10.1136/rmdopen-2023-003431. RMD Open. 2023. PMID: 37797966 Free PMC article.
The development of systemic sclerosis classification criteria.
Walker JG, Pope J, Baron M, Leclercq S, Hudson M, Taillefer S, Edworthy SM, Nadashkevich O, Fritzler MJ. Walker JG, et al. Among authors: fritzler mj. Clin Rheumatol. 2007 Sep;26(9):1401-9. doi: 10.1007/s10067-007-0537-x. Epub 2007 Feb 7. Clin Rheumatol. 2007. PMID: 17285223 Review.
Update on autoantibodies in systemic sclerosis.
Walker JG, Fritzler MJ. Walker JG, et al. Among authors: fritzler mj. Curr Opin Rheumatol. 2007 Nov;19(6):580-91. doi: 10.1097/BOR.0b013e3282e7d8f9. Curr Opin Rheumatol. 2007. PMID: 17917539
Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, Goulet JR, Rich E, Grodzicky T, Raymond Y, Senécal JL. Koenig M, et al. Among authors: fritzler mj. Arthritis Rheum. 2008 Dec;58(12):3902-12. doi: 10.1002/art.24038. Arthritis Rheum. 2008. PMID: 19035499 Free article.
Systemic sclerosis: establishing diagnostic criteria.
Hudson M, Fritzler MJ, Baron M; Canadian Scleroderma Research Group (CSRG). Hudson M, et al. Among authors: fritzler mj. Medicine (Baltimore). 2010 May;89(3):159-165. doi: 10.1097/MD.0b013e3181dde28d. Medicine (Baltimore). 2010. PMID: 20453602 Free article.
Autoantibodies in systemic sclerosis.
Mehra S, Walker J, Patterson K, Fritzler MJ. Mehra S, et al. Among authors: fritzler mj. Autoimmun Rev. 2013 Jan;12(3):340-54. doi: 10.1016/j.autrev.2012.05.011. Epub 2012 Jun 25. Autoimmun Rev. 2013. PMID: 22743034 Review.
Autoantibodies to the Rpp25 component of the Th/To complex are the most common antibodies in patients with systemic sclerosis without antibodies detectable by widely available commercial tests.
Mahler M, Satoh M, Hudson M, Baron M, Chan JY, Chan EK, Wick J, Fritzler MJ; Canadian Scleroderma Research Group. Mahler M, et al. Among authors: fritzler mj. J Rheumatol. 2014 Jul;41(7):1334-43. doi: 10.3899/jrheum.131450. Epub 2014 Jun 15. J Rheumatol. 2014. PMID: 24931955
462 results